Related Experiment Video
Updated: Jan 13, 2026

Circadian Entrainment of Drosophila Melanogaster
Published on: June 3, 2020
Circadian Clock Dysfunction Exacerbate Autistic-Like Behaviour and Wnt/β-Catenin Signalling Dysregulation in ASD Mice
Yuxing Zhang1, Yinan Chen1,2, Wu Li1
1Hunan University of Chinese Medicine, Changsha, Hunan Province, China.
Insights
Autism Spectrum Disorder (ASD) is linked to sleep issues and circadian clock disruption. Melatonin treatment improved autistic behaviors in mice by regulating the Wnt/β-catenin pathway, suggesting a therapeutic role.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Sleep disturbances affect 50-80% of children with Autism Spectrum Disorder (ASD).
- Circadian clock dysfunction and Bmal1 deficiency are implicated in ASD pathogenesis.
- Valproic acid (VPA) exposure in mice is a model for studying ASD-like behaviors.
Purpose of the Study:
- To investigate the role of circadian clock proteins in ASD.
- To examine the effects of Bmal1 deficiency on VPA-induced autistic behaviors.
- To evaluate the therapeutic potential of melatonin in an ASD mouse model.
Main Methods:
- Characterization of circadian protein expression patterns.
- Behavioral tests and Western blot analysis in VPA-exposed mice.
- Bmal1 knockout and melatonin treatment in VPA-exposed mice.
Main Results:
- VPA exposure induced autistic-like behaviors, altered circadian protein expression, and disrupted Wnt signaling.
- Bmal1 knockout exacerbated behavioral deficits and Wnt pathway impairment in VPA-exposed mice.
- Melatonin treatment reversed Wnt downregulation and improved behaviors in VPA-exposed mice.
Conclusions:
- Circadian dysregulation plays a role in ASD pathogenesis.
- Melatonin shows therapeutic potential for ASD-like behaviors via Wnt/β-catenin pathway modulation.
- Bmal1 may function as a co-activator in the Wnt-β-catenin signaling pathway.
Abstract:
Between 50% and 80% of children diagnosed with Autism Spectrum Disorder (ASD) are estimated to experience sleep disturbances, highlighting the importance of exploring the role of the circadian clock in ASD development. Previous studies have identified a potential link between Bmal1 deficiency and ASD in mouse models. In this study, we first characterise the expression patterns of circadian proteins. Subsequent behavioural tests and western blot analyses revealed that mice exposed to valproic acid (VPA) displayed autistic-like behaviours, along with altered circadian protein expression and disruption in Wnt signalling protein levels. Further studies showed that Bmal1 knockout exacerbates these behavioural changes and further impaired Wnt signalling and downstream protein expression in VPA-exposed mice. Notably, treatment with the circadian biomarker melatonin reversed Wnt downregulation and improved the behaviour deficit in VPA-exposed mice. The therapeutic effect of melatonin appears to be mediated by its regulation of the Wnt/β-catenin signalling pathway, which is linked to Bmal1-mediated circadian dysfunction. Together, our findings provide experimental evidence supporting the role of circadian dysregulation in ASD pathogenesis, highlight the therapeutic potential of melatonin in VPA-exposed mice, and suggest that Bmal1 may act as a co-activator in the Wnt-β-catenin signalling pathway.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Management of Insomnia
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Biological Clocks and Seasonal Responses

